4D Molecular Therapeutics Inc Ordinary Shares FDMT
News
4DMT to Host Investor Day on October 21, 2026
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
4DMT Announces New Employment Inducement Grants
4DMT to Participate in Upcoming Investor Conferences
4DMT Announces New Employment Inducement Grants
4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
4D Molecular Shares Rise Premarket on Partnership With Otsuka

